What is the first-line antibiotic for community-acquired pneumonia?

Treatment  ·  April 7, 2026

From the Guidelines

Background

Community-acquired pneumonia (CAP) is a major global health challenge affecting vulnerable populations including older adults, immunocompromised individuals, those with chronic conditions, and young children [3]. Streptococcus pneumoniae remains the most common bacterial cause of CAP, followed by Haemophilus influenzae [6].

Current Evidence for First-Line Antibiotic Selection

Pediatric Patients

The available sources provide clear recommendations for previously healthy children:

Amoxicillin is the first-line treatment for children who are adequately immunized against Haemophilus influenzae type b [1]. This recommendation is supported by:

For children with incomplete immunization against H. influenzae type b or Streptococcus pneumoniae, amoxicillin-clavulanate or second- or third-generation cephalosporins should be prescribed instead [1].

Macrolides should be considered in addition to amoxicillin in certain pediatric cases [1].

Adult Patients

The sources reference comprehensive guidelines for adult CAP management, including:

Limitations & Considerations

Important limitation: According to the available evidence in these sources, the specific first-line antibiotic recommendations for adult patients with CAP are not detailed in the provided abstracts [11, 12]. While these major clinical practice guidelines address empiric antibiotic selection, the actual antibiotic recommendations would require access to the full guideline documents.

The sources emphasize that:

Sources

[1]
Treatment of mild to moderate community-acquired pneumonia in previously healthy children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG-SIMG). — Ital J Pediatr, 2024
[2]
Clinical Pathway Revision Increases Amoxicillin Monotherapy and 5-Day Durations of Therapy for Pediatric Community-Acquired Pneumonia in the Emergency Department and Urgent Care: A Quality Improvement Initiative. — Ann Emerg Med, 2025
[3]
Community-acquired pneumonia. — Lancet, 2025
[4]
Updates on community acquired pneumonia management in the ICU. — Pharmacol Ther, 2021
[5]
Community-Acquired Pneumonia. — Ann Intern Med, 2022
[6]
Etiology of community-acquired pneumonia in adults: a systematic review. — Pneumonia (Nathan), 2020
[7]
Corticosteroids in Community-Acquired Bacterial Pneumonia: a Systematic Review, Pairwise and Dose-Response Meta-Analysis. — J Gen Intern Med, 2023
[8]
Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review. — Expert Rev Vaccines, 2023
[9]
Prevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis. — Lancet Child Adolesc Health, 2022
[10]
Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysis. — BMJ Open Respir Res, 2024
[11]
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. — Am J Respir Crit Care Med, 2019
[12]
Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline. — Am J Respir Crit Care Med, 2026

Frequently Asked Questions

What is the first-line antibiotic for community-acquired pneumonia in children?

Amoxicillin is the first-line treatment for previously healthy, adequately immunized children with community-acquired pneumonia. For children with incomplete immunization against Haemophilus influenzae type b or Streptococcus pneumoniae, amoxicillin-clavulanate or second- or third-generation cephalosporins should be used instead.

What bacteria most commonly cause community-acquired pneumonia?

Streptococcus pneumoniae is the most common bacterial cause of community-acquired pneumonia, followed by Haemophilus influenzae. These organisms remain the primary pathogens affecting vulnerable populations including older adults, immunocompromised individuals, and young children.

When should macrolides be used for pediatric community-acquired pneumonia?

Macrolides should be considered in addition to amoxicillin in certain pediatric cases of community-acquired pneumonia. The specific clinical situations warranting macrolide addition should be determined based on individual patient factors and current clinical guidelines.

Related Questions

Recommend some eye supplements Treatment Inicio de manejo en diabetes y Pre diabetes Treatment Una persona con lesion medular con un diagnóstico de paraplejia pero si camina con bastón qué método anticonceptivo puede usar ? Ampolla de un mes ola de 3 meses Treatment Una persona con lesion medular con un diagnóstico de paraplejia pero si camina con bastón qué método anticonceptivo puede usar ? Ampolla de un mes ola de 3 meses Treatment

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Mentor MD assumes no liability for clinical decisions based on this content.